Ann: Emyria Appoints Expert Neuropharmacologist for MDMA Program, page-2

  1. 108 Posts.
    lightbulb Created with Sketch. 64
    Interesting! Looks like Dr. Mat Martin-Iverson has previously published on two of these analouges - UWA-101 and UWA-121 - which have shown promising results in animal models of Parkinson's disease. Emyria is likely to be interested in these two compounds as a potential treatment for Parkinson's. I wonder if a human trial will follow?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $21.40M
Open High Low Value Volume
3.4¢ 3.5¢ 3.1¢ $221.0K 6.502M

Buyers (Bids)

No. Vol. Price($)
1 400000 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 392668 1
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.